Disease‐induced alterations in plasma drug‐binding proteins and their influence on drug binding percentages in dogs

Reference

• Abramson , FP . 1988 . Dose‐response behavior of the induction of a1‐acid glycoprotein by phenobarbital in the dog . Drug Metabolism and Disposition , 16 : 546 – 50 .
   PubMed Web of Science ®Google Scholar
• Belpaire , FM , DeRick , A , Dello , C , Fraeyman , N and Bogaert , MG . 1987 . a1‐acid glycoprotein and serum binding of drugs in healthy and diseased dogs . Journal of Veterinary Pharmacology and Therapeutics , 10 : 43 – 8 .
   PubMed Web of Science ®Google Scholar
• Benet , LZ and Williams , RL . 1996 . “ Design and optimization of dosage regimens; pharmacokinetic data ” . In Goodman & Gilman's The pharmacological basis of therapeutics. , 9th ed. , Edited by: Hardman , JG , Limbird , LE , Molinoff , PB , Ruddon , RW and Gilman , AG . 1650 – 1735 . New York : McGraw‐Hill .
   Google Scholar
• Condner , EC and Maslin , WR . 1992 . Investigation of renal protein loss in dogs with acute experimentally induced Ehrlichia canis infection . Am J Vet Res , 53 (3) : 294 – 9 .
   PubMed Web of Science ®Google Scholar
• Conner , JG and Eckersall , PD . 1988 . Acute phase response in the dog following surgical trauma . Research in Veterinary Science , 45 : 107 – 10 .
   PubMed Web of Science ®Google Scholar
• Dello , CP , Belpaire , FM , DeRick , A and Fraeyman , NH . 1988 . Influence of inflammation on serum concentration, molecular heterogeneity and drug binding properties of canine alpha‐1‐acid glycoprotein . Journal of Veterinary Pharmacology and Therapeutics , 11 : 71 – 6 .
   PubMed Web of Science ®Google Scholar
• Doumas , BT , Watson , WA and Biggs , HG . 1971 . Albumin standards and the measurement of serum albumin with bromcresol green . Clinica Chimica Acta , 31 : 87 – 96 .
   PubMed Web of Science ®Google Scholar
• Edwards , DJ , Lalka , D , Cerra , F and Slaughter , RL . 1982 . Alpha1‐acid glycoprotein concentration and protein binding in trauma . Clinical Pharmacology and Therapeutics , 31 : 62 – 7 .
   PubMed Web of Science ®Google Scholar
• Fishman , WH and Charlap , S . 1994 . “ The alpha‐ and beta‐adrenergic blocking drugs ” . In Cardiovascular pharmacology , Edited by: Parmley , WW and Chatterjee , K . 5.2 – 20 . Hong Kong : Wolfe .
   Google Scholar
• Fox , SM and Johnston , S.A. 1997 . Use of carprofen for the treatment of pain and inflammation in dogs . Journal of American Veterinary Medical Association , 210 (10) : 1493 – 98 .
   PubMed Web of Science ®Google Scholar
• Frey , HH and Rieh , B . 1981 . Pharmacokinetics of naproxen in the dog . Am J Vet Res , 42 (9) : 1615 – 7 .
   PubMed Web of Science ®Google Scholar
• Gilmour , MA and Walshaw , R . 1987 . Naproxen‐induced toxicosis in dog . J Am Vet Med Assoc , 191 (11) : 1431 – 32 .
   PubMed Web of Science ®Google Scholar
• Hvidberg , EF and Dam , M . 1976 . Clinical pharmacokinetics of anticonvulsants . Clinical Pharmacokinetics , 1 (3) : 161 – 88 .
   PubMedGoogle Scholar
• Kinoshita , T , Son , D‐S , Shimoda , M and Kokue , E . 1995 . Impact of age‐related alteration of plasma alpha1‐acid glycoprotein concentration on erythromycin pharmacokinetics in pigs . Am J Vet Res , 56 : 362 – 5 .
   PubMed Web of Science ®Google Scholar
• Kremer , JMH , Wilting , J and Janssen , LH . 1988 . Drug binding to human alpha‐1‐acid glycoprotein in health and disease . Pharmacological Reviews , 40 : 1 – 47 .
   PubMed Web of Science ®Google Scholar
• McKellar , QA , Delatour , P and Lees , P . 1994 . Stereospecific pharmacodynamics and pharmacokinetics of carprofen in the dog . Journal of Veterinary Pharmacology and Therapeutics , 17 (6) : 447 – 54 .
   PubMed Web of Science ®Google Scholar
• McKellar , QA , Galbraith , EA , Bogan , JA , Russell , CS , Hooke , RE and Lees , P . 1989 . Flunixin pharmacokinetics and serum thromboxane inhibition in the dog . Vet Rec , 124 : 651 – 4 .
   PubMed Web of Science ®Google Scholar
• Neff‐Davis , CA . 1988 . “ Therapeutic drug monitoring in the veterinary clinics ” . In Clinical pharmacology , Edited by: Papich , M.G. vol 18 , 161 – 79 . Philadelphia : W.B. Saunders Company . num 6.
   Google Scholar
• Nielsen , UCK , Ostergard , EH and Frey , HH . 1969 . Versuche zur dosierung von Phenylbutazon beim Hund . D.T.W., , 76 : 371 – 87 .
   Google Scholar
• Nilsen , OG and Jacobsen , S . 1976 . The influence of salts and differences in protein isolation procedure on the binding of quinidine to human serum albumin . Biochemical Pharmacology , 25 : 1261 – 6 .
   PubMed Web of Science ®Google Scholar
• Ogilvie , GK , Walters , LM , Greeley , SG , Henkel , SE and Salman , MD . 1993 . Concentration of a1‐acid glycoprotein in dogs with malignant neoplasia . J Am Vet Med Assoc , 203 (8) : 1144 – 6 .
   PubMed Web of Science ®Google Scholar
• Plaisance , KI , Drusano , GL , Forrest , A , Townsend , RJ and Standiford , HC . 1988 . Pharmacokinetic Evaluation of Two Dosage Regimens of Clindamycin Phosphate . Agents and Chemotherapy , 33 (5) : 618 – 20 .
   Web of Science ®Google Scholar
• Rakhit , A , Kunitani , M , Holford , NH and Riegelman , S . 1982 . Improved liquid‐ chromatographic assay of quinidine and its metabolites in biological fluids . Clinical Chemistry , 28 (7) : 1505 – 9 .
   PubMed Web of Science ®Google Scholar
• Rick , A de , Belpaire , F , Bogaert , M and Rosseel , MT . 1985 . Influence of enhanced serum protein binding on the pharmacokinetics and the antiarrhythmic effect of lidocaine in the dog . European Association of Veterinary Pharmacology and Toxicology, 3rd Congress . 1985 . pp. 113
   Google Scholar
• Rikihisa , Y , Yamamoto , S , Kwak , I , Iqbal , Z , Kociba , G , Mott , J and Chichanasiriwithaya , W . 1994 . C‐reactive protein and a1‐acid glycoprotein levels in dogs infected with Ehrlichia canis . Journal of Clin Microbiol , 32 (4) : 912 – 7 .
   PubMed Web of Science ®Google Scholar
• Roudebush , P and Morse , GE . 1981 . Naproxen toxicosis in dog . J Am Vet Med Assoc , 179 (8) : 805 – 6 .
   PubMed Web of Science ®Google Scholar
• Shimoda , M , Kokue , E , Hayama , T and Vree , TB . 1989 . Effect of albumin distribution ‐ A simulation analysis of the effect of altered albumin distribution on the apparent volume of distribution and apparent elimination rate constant of drugs. Pharmaceutisch Weekblad . Scientific Edition , 11 : 87 – 91 .
   Google Scholar
• Sugiyama , Y . 1985 . “ Protein binding examinations ” . In Applied pharmacokinetics ‐ theory and experiments , Edited by: Hanano , M , Umemura , K and Iga , T . 337 – 80 . Tokyo : SOFT SCIENCE .
   Google Scholar
• Tagawa , Y , Kokue , E , Shimoda , M and Son , D‐S . 1994 . alpha1‐acid glycoprotein‐binding as a factor in age‐related changes in the pharmacokinetics of trimethoprim in piglets . Vet Quart , 16 : 13 – 7 .
   PubMed Web of Science ®Google Scholar
• Vree , TB , Shimoda , M , Driessen , JJ , Guelen , PJM , Janssen , TJ , Termond , EFS , Dalen , R van , Hafkenscheid , CM and Dirksen , MSC . 1989 . Decreased plasma albumin concentration results in increased volume of distribution and decreased elimination of midazolam in intensive care patients . Clinical Pharmacology and Therapeutics , 46 (5) : 537 – 44 .
   PubMed Web of Science ®Google Scholar
• Yacobi , A and Levy , G . 1975 . Comparative pharmacokinetics of coumarin anticoagulants XIV: relationship between protein binding, distribution, and elimination kinetics of warfarin in rats . Journal of Pharmaceutical Sciences , 64 (10) : 1660 – 4 .
   PubMed Web of Science ®Google Scholar
• Yacobi , A and Levy , G . 1979 . Effect of serum protein binding on sulfisoxazole distribution, metabolism, and excretion in rats . Journal of Pharmaceutical Sciences , 68 (6) : 742 – 6 .
   PubMed Web of Science ®Google Scholar
• Zeineh , RA , Barrett , B , Niemirowski , L and Fiorella , BJ . 1972 . Turnover rate of orosomucoid in the dog with sterile abscess . American Journal of Physiology , 222 (5) : 1326 – 32 .
   PubMed Web of Science ®Google Scholar
• Zini , R , Riant , P , Barre , R and Tillement , JP . 1990 . Disease‐induced variations in plasma protein levels. Implication for drug dosage regimens (Part I) . Clinical Pharmacokinetics , 19 (2) : 145 – 59 .
   Web of Science ®Google Scholar
• Zini , R , Riant , P , Barre , R and Tillement , JP . 1990 . Disease‐induced variations in plasma protein levels. Implication for drug dosage regimens (Part II) . Clinical Pharmacokinetics , 19 (3) : 218 – 29 .
   PubMed Web of Science ®Google Scholar
• Laboratory of Veterinary Pharmacology, Department of Veterinary Medicine, Tokyo University of Agriculture and Technology, Saiwaicho 3–5‐8, Fuchushi, Tokyo, 183–0054, Japan.
   Google Scholar